© 2021 BioMarin. All rights reserved.

BioMarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco
Jan 3, 2018

SAN RAFAEL, Calif., Jan. 3, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 8:30 am PT, or 11:30 am ET, in San Francisco, California. To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following the event.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:


Investors                                                   

Media

Traci McCarty                                            

Debra Charlesworth

BioMarin Pharmaceutical Inc.                     

BioMarin Pharmaceutical Inc.

(415) 455-7558                                            

(415) 455-7451

 

SOURCE BioMarin Pharmaceutical Inc.